“I think he was the most brilliant person I’ve ever met," one long-time colleague said. 

The new analysis, presented during Heart Rhythm 2022, focused on patients treated at a high-volume facility during the COVID-19 pandemic. 

Heart Rhythm 2022, held from April 28 to May 1 in San Francisco, included a wide range of studies presented by some of the industry's leading specialists. 

The FDA and Medtronic warn some Heartware Ventricular Assist Device (HVAD) systems have a defect that may cause pump thrombosis.

New data from the STROKE AF clinical trial shows large and small vessel ischemic stroke patients who receive short-term or intermittent monitoring with Holter and 30-day external monitors had fewer AFib episodes detected that continuous implantable cardiac monitors.

Researchers examined data from more than 750,000 heart failure hospitalizations, sharing their findings in JACC: Heart Failure. 

A new analysis found that 30-day outcomes do not significantly change when LAAO patients go home the same day as their procedure. 

Researchers introduced decision support tools to 13 different hospitals, tracking the overall impact on shared-decision making and patient knowledge.